ReproCELL Incorporated (FRA:6RC)

Market Cap	93.94M -10.1%
Revenue (ttm)	13.68M -7.3%
Net Income	-1.76M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.7850
Previous Close	0.7450
Day's Range	0.7850 - 0.7850
52-Week Range	0.5200 - 1.1000
Beta	n/a
RSI	54.97
Earnings Date	May 13, 2026

About ReproCELL

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2003
• Employees: 99
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6RC

Financial Performance

Financial numbers in JPY